Mnk targeting enhances vulnerability of medulloblastoma stem -like cancer cells to PI3K-pllOalpha inhibition

被引:0
|
作者
Bell, Jonathan B.
Eckerdt, Frank
Ma, Quanhong
Clymer, Jessica R.
Goldman, Stewart
Hashizume, Rintaro
Platanias, Leonidas C.
机构
关键词
D O I
10.1158/1538-7445.AM2016-LB-009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
LB-009
引用
收藏
页数:3
相关论文
共 50 条
  • [1] DNMT targeting enhances vulnerability of glioblastoma cells to MNK inhibition
    Mazewski, Candice
    Eckerdt, Frank
    Baran, Aneta
    Fischietti, Mariafausta
    Vagadia, Purav P.
    Perez, Ricardo E.
    James, Charles D.
    Schiltz, Gary E.
    Platanias, Leonidas C.
    CANCER RESEARCH, 2022, 82 (12)
  • [2] Inhibition of PI3K Signalling Selectively Affects Medulloblastoma Cancer Stem Cells
    Frasson, Chiara
    Rampazzo, Elena
    Accordi, Benedetta
    Beggio, Giacomo
    Pistollato, Francesca
    Basso, Giuseppe
    Persano, Luca
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [3] Potent Antineoplastic Effects of Combined PI3Kα-MNK Inhibition in Medulloblastoma
    Eckerdt, Frank
    Bell, Jonathan B.
    Beauchamp, Elspeth M.
    Clymer, Jessica
    Blyth, Gavin T.
    Kosciuczuk, Ewa M.
    Ma, Quanhong
    Chen, David Z.
    Horbinski, Craig
    Goldman, Stewart
    Munshi, Hidayatullah G.
    Hashizume, Rintaro
    Platanias, Leonidas C.
    MOLECULAR CANCER RESEARCH, 2019, 17 (06) : 1305 - 1315
  • [4] Pharmacological mTOR targeting enhances the antineoplastic effects of selective PI3Kα inhibition in medulloblastoma
    Eckerdt, Frank
    Clymer, Jessica
    Bell, Jonathan B.
    Beauchamp, Elspeth M.
    Blyth, Gavin T.
    Goldman, Stewart
    Platanias, Leonidas C.
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [5] Pharmacological mTOR targeting enhances the antineoplastic effects of selective PI3Kα inhibition in medulloblastoma
    Frank Eckerdt
    Jessica Clymer
    Jonathan B. Bell
    Elspeth M. Beauchamp
    Gavin T. Blyth
    Stewart Goldman
    Leonidas C. Platanias
    Scientific Reports, 9
  • [6] Targeting cancer stem cells via inhibition of PI3K/AKT pathway alone and in combination with autophagy blockade
    Graham, Regina M.
    Middleton, Andrew
    Benito, Daniel A.
    Uddin, Raisa
    Zhang, Baoyu
    Walters, Winston
    Bregy, Amade
    Vanni, Steven
    Komotar, Ricardo J.
    MOLECULAR CANCER THERAPEUTICS, 2015, 14 (07)
  • [7] Targeting breast cancer stem cells through inhibition of PI3-K/AktA#914;-catenin signaling
    Hasan, Korkaya
    Paulson, Amanda
    Wicha, Max
    CANCER RESEARCH, 2009, 69
  • [8] NRP1 inhibition modulates radiosensitivity of medulloblastoma by targeting cancer stem cells
    Manon Douyère
    Caifeng Gong
    Mylène Richard
    Nadia Pellegrini-Moïse
    Joël Daouk
    Julien Pierson
    Pascal Chastagner
    Cédric Boura
    Cancer Cell International, 22
  • [9] NRP1 inhibition modulates radiosensitivity of medulloblastoma by targeting cancer stem cells
    Douyere, Manon
    Gong, Caifeng
    Richard, Mylene
    Pellegrini-Moise, Nadia
    Daouk, Joel
    Pierson, Julien
    Chastagner, Pascal
    Boura, Cedric
    CANCER CELL INTERNATIONAL, 2022, 22 (01)
  • [10] TARGETING SHH SIGNALING VIA PI3K/MTOR INHIBITION IN MEDULLOBLASTOMA AND EWING SARCOMA
    Clymer, Jessica
    Eckerd, Frank
    Bell, Jonathan
    Lulla, Rishi
    Goldman, Stewart
    Platanias, Leonidas
    NEURO-ONCOLOGY, 2017, 19 : 47 - 47